Skip to content
healthcare.dev

A-21

NDC 58264-0313, ALTERNARIA ALTERNATA, ASPERGILLUS NIGER VAR. NIGER, COCHLIOBOLUS SPICIFER, GIBBERELLA FUJIKUROI, COCHLIOBOLUS SATIVUS, CLADOSPORIUM BRUHNEI, MUCOR PLUMBEUS, PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM, AUREOBASIDIUM PULLULANS VAR. PULLUTANS, and RHIZOPUS STOLONIFER, solution, from DNA Labs, Inc..

Product NDC
58264-0313
Status
Listed
Labeler
DNA Labs, Inc.
Dosage form
SOLUTION
Route
SUBLINGUAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0313 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALTERNARIA ALTERNATA30 [hp_X]/mL
  • ASPERGILLUS NIGER VAR. NIGER30 [hp_X]/mL
  • COCHLIOBOLUS SPICIFER30 [hp_X]/mL
  • GIBBERELLA FUJIKUROI30 [hp_X]/mL
  • COCHLIOBOLUS SATIVUS30 [hp_X]/mL
  • CLADOSPORIUM BRUHNEI30 [hp_X]/mL
  • MUCOR PLUMBEUS30 [hp_X]/mL
  • PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM30 [hp_X]/mL
  • AUREOBASIDIUM PULLULANS VAR. PULLUTANS30 [hp_X]/mL
  • RHIZOPUS STOLONIFER30 [hp_X]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]

Package NDCNDC-11Package
58264-0313-15826403130129.57 mL in 1 BOTTLE, GLASS (58264-0313-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58264-0313 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0313 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58264-0313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.